Colgate-Palmolive Company: Q2 2026 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2026, for Colgate-Palmolive Company (NYSE: CL). The Company operates in two primary segments: Oral, Personal and Home Care, and Pet Nutrition (Hill's). During the period, the Company realigned its geographic reporting structure, combining Europe and Africa/Eurasia into a new EMEA segment and moving Russia and Belarus to the Asia Pacific segment. The Company is a large accelerated filer with approximately 797 million shares of common stock outstanding as of June 30, 2026.
Key Financial Metrics
| Metric (in millions, except per share) | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Net Sales | $5,361 | $5,110 | $10,686 | $10,021 |
| Gross Profit | $3,296 | $3,069 | $6,522 | $6,056 |
| Gross Margin | 61.5% | 60.1% | 61.0% | 60.4% |
| Operating Profit | $1,016 | $1,080 | $1,980 | $2,156 |
| Net Income (Attributable to Colgate) | $693 | $743 | $1,339 | $1,433 |
| Diluted EPS | $0.86 | $0.91 | $1.67 | $1.76 |
| Operating Cash Flow (YTD) | $1,742 | $1,484 | $1,742 | $1,484 |
| Total Debt | $7,857 | $7,988 (Dec 31, 2025) | $7,857 | $7,988 |
| Cash and Equivalents | $1,370 | $1,288 (Dec 31, 2025) | $1,370 | $1,288 |
Material Changes vs. Prior Period
- Sales Growth: Worldwide net sales increased 4.9% in Q2 2026 and 6.6% YTD, driven by volume growth (0.9% Q2, 1.0% YTD), net selling price increases (1.6% Q2, 1.9% YTD), and favorable foreign exchange (2.4% Q2, 3.8% YTD). Organic sales growth was 2.4% in Q2 and 2.6% YTD.
- Profitability Pressure: GAAP operating profit decreased 6% in Q2 and 8% YTD. This decline was primarily due to $129 million in pre-tax charges in Q2 (and $305 million YTD) related to the "Strategic Growth and Productivity Program."
- Non-GAAP Performance: Excluding restructuring and other unusual items, non-GAAP operating profit increased 5% in Q2 and 5% YTD. Non-GAAP diluted EPS increased 8% in Q2 ($0.99) and 8% YTD ($1.97).
- Segment Performance: Latin America and Asia Pacific showed strong organic growth (5.3% and 5.2% respectively in Q2). North America organic sales declined 3.0% in Q2. Hill's Pet Nutrition organic sales grew 2.1% in Q2.
- Costs: Selling, general, and administrative (SG&A) expenses increased 9% in Q2, driven by higher advertising investment ($99 million increase) and overhead expenses, partially offset by cost savings initiatives.
Guidance, Outlook, and Risks
- Strategic Growth and Productivity Program: The Board approved an expansion of this program in April 2026. Cumulative pre-tax charges are now estimated between $350 million and $550 million, with substantially all charges expected by December 31, 2028. Annualized pre-tax savings are projected at $200 million to $300 million.
- Outlook: Management expects global macroeconomic and geopolitical conditions to remain challenging, citing the conflict in the Middle East, trade relations (tariffs), and inflationary pressures. They anticipate softness across categories to continue through the second half of 2026.
- Capital Allocation: The Company increased its quarterly dividend to $0.53 per share in Q2 2026. Share repurchases totaled approximately $597 million YTD. Capital expenditures for 2026 are expected to be approximately 3.0% of net sales.
- Risks and Contingencies:
- Talcum Powder Litigation: 525 individual cases were pending as of June 30, 2026. The Company believes it has strong legal grounds to contest these.
- Brazilian Tax Matters: Ongoing disputes regarding interest deductions and foreign exchange losses related to a 1995 acquisition, with assessments totaling approximately $105 million.
- Geopolitical: Risks related to the war in Ukraine and the conflict in the Middle East, including supply chain disruptions and currency volatility.
Key Facts for Investor Verification
- Restructuring Impact: Verify the timing and cash impact of the remaining $350-$550 million Strategic Growth and Productivity Program charges, as these significantly distort GAAP earnings.
- North America Decline: Investigate the drivers behind the 3.0% organic sales decline in North America, specifically in the toothpaste and personal care categories.
- Margin Sustainability: Assess whether the 140 basis point gross margin expansion in Q2 can be sustained given the noted 220 basis point headwind from higher raw material costs.
- Legal Exposure: Monitor the status of the 525 pending talcum powder cases and the Brazilian tax disputes, as adverse outcomes could be material.
- Foreign Exchange: Evaluate the sensitivity of future results to currency fluctuations, particularly in hyper-inflationary economies like Argentina, Nigeria, and Turkey, which contributed significantly to reported sales growth.